NCT02593682View on ClinicalTrials.gov

The Role of Orexin in Human Panic Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

March 13, 2020

Study Completion Date

March 13, 2020

Conditions
Panic Disorder
Interventions
DRUG

suvorexant

DRUG

placebo

Trial Locations (1)

93701

UCSF Fresno Medical Education Program, Fresno

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT02593682 - The Role of Orexin in Human Panic Disorder | Biotech Hunter | Biotech Hunter